Catalyst Wire Dossier Catalyst Wire Dossier

HARVONI

Ledipasvir and Sofosbuvir · Gilead Sciences, Inc
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for HARVONI, covering 2014-09-26 to 2026-01-09. Get the full timeline:

Most recent: EMA Authorised: Harvoni (ledipasvir;sofosbuvir) — Gilead Sciences Ireland UC

See pricing